TrialClinical cancer research : an official journal of the American Association for Cancer Research2025

Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses.

Stefan G van Ravensteijn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.